{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T01:16:53Z","timestamp":1770081413298,"version":"3.49.0"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Peritonitis is considered as one of the most serious complications that cause hospitalization in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). There is limited evidence on the impact of the parathyroid hormone (PTH) on the first peritoneal dialysis (PD)-associated peritonitis episode. We aimed to investigate the influence of serum intact parathyroid hormone (iPTH) on peritonitis in patients undergoing PD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a retrospective cohort study. Patients undergoing initial CAPD from a single center in China were enrolled. The baseline characteristics and clinical information were recorded. The primary outcome of interest was the occurrence of the first PD-associated peritonitis episode. Five Cox proportional hazard models were constructed in each group set. In group set 1, all participants were divided into three subgroups by tertiles of the serum concentration of iPTH; in group set 2, all participants were divided into three subgroups based on the serum concentration of iPTH with 150\u00a0pg\/ml interval (&amp;lt;150, 150\u2013300, and &amp;gt;300\u00a0pg\/ml). Hazard ratios and 95% confidence intervals (CIs) were calculated for each model. The multivariate linear regression analysis elimination procedure assessed the association between the clinical characteristics at baseline and the iPTH levels. Restricted cubic spline models were constructed, and stratified analyses were also conducted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 582 patients undergoing initial PD (40% women; mean age, 45.1\u00a0\u00b1\u00a011.5\u00a0years) from a single center in China were recruited. The median follow-up duration was 25.3\u00a0months. Multivariate Cox regression analysis showed that, in the fully adjusted model, a higher serum iPTH level (tertile 3, iPTH\u00a0&amp;gt;300\u00a0pg\/ml) was significantly associated with a higher risk of PD-associated peritonitis at 3\u00a0years [tertile 3: hazard ratio (HR)\u00a0=\u00a01.53, 95%CI\u00a0=\u00a01.03\u20132.55, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.03; iPTH\u00a0&amp;gt;\u00a0300\u00a0pg\/ml: HR\u00a0=\u00a01.57, 95%CI\u00a0=\u00a01.08\u20132.27, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.02]. The hazard ratio for every 100\u00a0pg\/ml increase in serum iPTH level was 1.12 (95%CI\u00a0=\u00a01.05\u20131.20, <jats:italic>p<\/jats:italic>\u00a0&amp;lt;\u00a00.01) in the total cohort when treating iPTH as a continuous variable.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>An elevated iPTH level was significantly associated with an increased risk of peritonitis in patients undergoing CAPD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1081543","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T05:45:56Z","timestamp":1679895956000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Relationship between serum iPTH and peritonitis episodes in patients undergoing continuous ambulatory peritoneal dialysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Zihao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duopin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangpu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaokang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangsuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: A systematic review","volume":"385","author":"Liyanage","year":"2015","journal-title":"Lancet (London England)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"A8","DOI":"10.1053\/j.ajkd.2022.02.001","article-title":"Us renal data system 2021 annual data report: Epidemiology of kidney disease in the united states","volume":"79","author":"Johansen","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000514550","article-title":"Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy","volume":"52","author":"Thurlow","year":"2021","journal-title":"Am J Nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.12703\/p7-57","article-title":"Recent advances in the management of peritoneal dialysis patients","volume":"7","author":"Saxena","year":"2015","journal-title":"F1000Prime Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1959.03010080025004","article-title":"Peritoneal dialysis. 1. technique and applications","volume":"170","author":"Maxwell","year":"1959","journal-title":"J Am Med Assoc"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016010112","article-title":"The current state of peritoneal dialysis","volume":"27","author":"Mehrotra","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1177\/08968608221080586","article-title":"Ispd peritonitis guideline recommendations: 2022 update on prevention and treatment","volume":"42","author":"Li","year":"2022","journal-title":"Peritoneal Dialysis Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.14631218","article-title":"Peritoneal dialysis-associated peritonitis","volume":"14","author":"Szeto","year":"2019","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy204","article-title":"Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the peritoneal dialysis outcomes and practice patterns study","volume":"34","author":"Boudville","year":"2019","journal-title":"Nephrology dialysis Transplant"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2011121135","article-title":"Recent peritonitis associates with mortality among patients treated with peritoneal dialysis","volume":"23","author":"Boudville","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu050","article-title":"Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis","volume":"29","author":"Cho","year":"2014","journal-title":"Nephrology Dialysis Transplant"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2009.00108","article-title":"Risk factors for peritoneal dialysis-associated peritonitis: The role of oral active vitamin d","volume":"30","author":"Rudnicki","year":"2010","journal-title":"Peritoneal Dialysis Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.715209","article-title":"Ongoing exposure to peritoneal dialysis fluid alters resident peritoneal macrophage phenotype and activation propensity","volume":"12","author":"Sutherland","year":"2021","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1177\/089686080502500413","article-title":"A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis","volume":"25","author":"Chow","year":"2005","journal-title":"Peritoneal Dialysis Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/55.5.523","article-title":"Serum calcium survey for hyperparathyroidism: Results in 50,000 clinic patients","volume":"55","author":"Boonstra","year":"1971","journal-title":"Am J Clin Pathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.3390\/biom11111570","article-title":"The parathyroid hormone-related Protein\/Parathyroid hormone 1 receptor axis in adipose tissue","volume":"11","author":"Izquierdo-Lahuerta","year":"2021","journal-title":"Biomolecules"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.869330","article-title":"Low parathyroid hormone versus secondary hyperparathyroidism and survival in patients undergoing hemodialysis: A propensity-matched analysis","volume":"13","author":"Guo","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and pth: The dialysis outcomes and practice patterns study (Dopps)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.06.041","article-title":"Parathyroid hormone metabolism and signaling in health and chronic kidney disease","volume":"90","author":"Evenepoel","year":"2016","journal-title":"Kidney Int"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.06.023","article-title":"Diagnostic accuracy of bone turnover markers and bone histology in patients with ckd treated by dialysis","volume":"67","author":"Sprague","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4155","article-title":"The ckd-mbd syndrome: Hysteresis in pth involvement and pth administration for its management","volume":"35","author":"Pazianas","year":"2020","journal-title":"J Bone Mineral Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/j.ajkd.2007.04.010","article-title":"Changes in serum 25-hydroxyvitamin d and plasma intact pth levels following treatment with ergocalciferol in patients with ckd","volume":"50","author":"Al-Aly","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"F1000 Faculty Rev-1077","DOI":"10.12688\/f1000research.22636.1","article-title":"Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease","volume":"9","author":"Rodr\u00edguez-Ortiz","year":"2020","journal-title":"F1000Research"},{"key":"B24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3747\/pdi.2016.00078","article-title":"Ispd peritonitis recommendations: 2016 update on prevention and treatment","volume":"36","author":"Li","year":"2016","journal-title":"Peritoneal Dialysis Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq304","article-title":"Calcium, phosphorus, pth and death rates in a Large sample of dialysis patients from Latin america. the cores study","volume":"26","author":"Naves-D\u00edaz","year":"2011","journal-title":"Nephrology Dialysis Transplant"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4266","article-title":"Association between low density lipoprotein and all cause and cause specific mortality in Denmark: Prospective cohort study","volume":"371","author":"Johannesen","year":"2020","journal-title":"BMJ (Clinical Res ed)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1053\/j.ajkd.2021.03.022","article-title":"Variation in peritoneal dialysis-related peritonitis outcomes in the peritoneal dialysis outcomes and practice patterns study (Pdopps)","volume":"79","author":"Al Sahlawi","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2100152","article-title":"Peritoneal dialysis","volume":"385","author":"Teitelbaum","year":"2021","journal-title":"New Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1053\/j.ajkd.2019.09.016","article-title":"Peritoneal dialysis-related infection rates and outcomes: Results from the peritoneal dialysis outcomes and practice patterns study (Pdopps)","volume":"76","author":"Perl","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.12321216","article-title":"Multicenter registry analysis of center characteristics associated with technique failure in patients on incident peritoneal dialysis","volume":"12","author":"Htay","year":"2017","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00188","article-title":"Peritoneal dialysis and its local and systemic complications: From the bench to the clinic","volume":"11","author":"Witowski","year":"2020","journal-title":"Front Physiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.03.014","article-title":"Targeting toll-like receptors with soluble toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis","volume":"94","author":"Raby","year":"2018","journal-title":"Kidney Int"},{"key":"B33","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0272-6386(04)00941-2","article-title":"Antimicrobial agents to prevent peritonitis in peritoneal dialysis: A systematic review of randomized controlled trials","volume":"44","author":"Strippoli","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3109\/0886022x.2014.927771","article-title":"Implementation of a continuous quality improvement program reduces the occurrence of peritonitis in pd","volume":"36","author":"Wang","year":"2014","journal-title":"Renal failure"},{"key":"B35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2215\/cjn.07970811","article-title":"A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: The Mp3 study","volume":"7","author":"McQuillan","year":"2012","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm242","article-title":"Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients","volume":"22","author":"Han","year":"2007","journal-title":"Nephrology dialysis Transplant"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.10.008","article-title":"A comparison of peritonitis rates from the united states renal data system database: Capd versus continuous cycling peritoneal dialysis patients","volume":"45","author":"Oo","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B38","article-title":"Aging is an important risk factor for peritoneal dialysis-associated peritonitis","volume":"28","author":"Okayama","year":"2012","journal-title":"Adv peritoneal Dialysis Conf Peritoneal Dialysis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/483250","article-title":"Risk factors associated with peritoneal-Dialysis-Related peritonitis","volume":"2012","author":"Kerschbaum","year":"2012","journal-title":"Int J Nephrol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.09750913","article-title":"Renal control of calcium, phosphate, and magnesium homeostasis","volume":"10","author":"Blaine","year":"2015","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2016.00563","article-title":"The calcium-sensing receptor and the parathyroid: Past, present, future","volume":"7","author":"Conigrave","year":"2016","journal-title":"Front Physiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1603","article-title":"Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active","volume":"95","author":"Shimada","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.05.019","article-title":"Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease","volume":"90","author":"Singh","year":"2016","journal-title":"Kidney Int"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00708","article-title":"Fgf23 induction of O-linked n-acetylglucosamine regulates il-6 secretion in human bronchial epithelial cells","volume":"9","author":"Krick","year":"2018","journal-title":"Front In Endocrinol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2013.147","article-title":"Fgf-23 and secondary hyperparathyroidism in chronic kidney disease","volume":"9","author":"Silver","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/01.asn.0000133041.27682.a2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 kdigo chronic kidney disease-mineral and bone disorder (Ckd-mbd) guideline update: What's changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2018.264","article-title":"Low parathyroid hormone level predicts infection-related mortality in incident dialysis patients: A prospective cohort study","volume":"35","author":"Hong","year":"2020","journal-title":"Korean J Internal Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1177\/0896860820918131","article-title":"High alkaline phosphatase and low intact parathyroid hormone associate with worse clinical outcome in peritoneal dialysis patients","volume":"41","author":"Chen","year":"2021","journal-title":"Peritoneal Dialysis Int"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2013.00110","article-title":"Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis","volume":"34","author":"Rhee","year":"2014","journal-title":"Peritoneal Dialysis Int"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2017.07.019","article-title":"Kdoqi us commentary on the 2017 kdigo clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (Ckd-mbd)","volume":"70","author":"Isakova","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/468574","article-title":"Protective effects of paricalcitol on peritoneal remodeling during peritoneal dialysis","volume":"2015","author":"Stavenuiter","year":"2015","journal-title":"BioMed Res Int"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-6686.2013.12009.x","article-title":"Comparison of sevelamer and calcium carbonate on endothelial function and inflammation in patients on peritoneal dialysis","volume":"39","author":"Chennasamudram","year":"2013","journal-title":"J Ren Care"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-011-1551-1","article-title":"Sevelamer use and incidence of peritonitis in peritoneal dialysis","volume":"123","author":"Kerschbaum","year":"2011","journal-title":"Wien Klin Wochenschr"},{"key":"B55","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12882-021-02241-0","article-title":"Low serum parathyroid hormone is a risk factor for peritonitis episodes in incident peritoneal dialysis patients: A retrospective study","volume":"22","author":"Yang","year":"2021","journal-title":"BMC Nephrol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/s41598-020-80938-2","article-title":"Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients","volume":"11","author":"Liao","year":"2021","journal-title":"Sci Rep"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1177\/089686080902902S28","article-title":"Insulin resistance and glucose homeostasis in peritoneal dialysis","author":"Fortes","year":"2009","journal-title":"Peritoneal Dialysis Int"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2013.00001","article-title":"Associations between serum-intact parathyroid hormone, serum 25-hydroxyvitamin d, oral vitamin d analogs and metabolic syndrome in peritoneal dialysis patients: A multi-center cross-sectional study","volume":"34","author":"Dong","year":"2014","journal-title":"Peritoneal Dialysis Int"},{"key":"B59","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S1658-3612(08)70052-0","article-title":"Parathyroid hormone: Effects on glucose homeostasis and insulin sensitivity in chronic renal failure patients on regular hemodialysis","volume":"3","author":"Ahamed","year":"2008","journal-title":"J Taibah Univ Med Sci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e0225316","DOI":"10.1371\/journal.pone.0225316","article-title":"Effect of diabetes on incidence of peritoneal dialysis-associated peritonitis","volume":"14","author":"Ueda","year":"2019","journal-title":"PLoS One"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.06620613","article-title":"Metabolic syndrome in peritoneal dialysis patients: Choice of diagnostic criteria and prognostic implications","volume":"9","author":"Szeto","year":"2014","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"B62","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2478\/jtim-2021-0025","article-title":"Effects of des-acyl ghrelin on insulin sensitivity and macrophage polarization in adipose tissue","volume":"9","author":"Yuan","year":"2021","journal-title":"J Trans Internal Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1177\/089686080402400408","article-title":"Obesity is a risk factor for peritonitis in the Australian and new Zealand peritoneal dialysis patient populations","volume":"24","author":"McDonald","year":"2004","journal-title":"Peritoneal Dialysis Int"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2007060645","article-title":"New insights into nephrogenic systemic fibrosis","volume":"18","author":"Swaminathan","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.11.003","article-title":"Pth\/Pthrp receptor mediates cachexia in models of kidney failure and cancer","volume":"23","author":"Kir","year":"2016","journal-title":"Cell Metab"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1681\/asn.v4101814","article-title":"A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia","volume":"4","author":"Amann","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3390\/toxins12030189","article-title":"Parathyroid hormone: A uremic toxin","volume":"12","author":"Duque","year":"2020","journal-title":"Toxins (Basel)"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.12.030","article-title":"Cx3cl1-Cx3cr1 interaction mediates macrophage-mesothelial cross talk and promotes peritoneal fibrosis","volume":"95","author":"Helmke","year":"2019","journal-title":"Kidney Int"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9610(99)00194-4","article-title":"Effects of a parathyroidectomy on the immune system and nutritional condition in chronic dialysis patients with secondary hyperparathyroidism","volume":"178","author":"Yasunaga","year":"1999","journal-title":"Am J Surg"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.147","article-title":"Effect of parathyroid hormone on human T cell activation","volume":"37","author":"Klinger","year":"1990","journal-title":"Kidney Int"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.01.017","article-title":"Machine-learning algorithms define pathogen-specific local immune fingerprints in peritoneal dialysis patients with bacterial infections","volume":"92","author":"Zhang","year":"2017","journal-title":"Kidney Int"},{"key":"B72","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3747\/pdi.2015.00100","article-title":"The association of individual and regional socioeconomic status on initial peritonitis and outcomes in peritoneal dialysis patients: A propensity score-matched cohort study","volume":"36","author":"Wang","year":"2016","journal-title":"Peritoneal Dialysis Int"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2020.1804401","article-title":"The influence of seasonal factors on the incidence of peritoneal dialysis-associated peritonitis","volume":"42","author":"Zeng","year":"2020","journal-title":"Renal failure"}],"updated-by":[{"DOI":"10.3389\/fendo.2023.1208563","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000}}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1081543\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T09:07:26Z","timestamp":1684400846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1081543\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":73,"alternative-id":["10.3389\/fendo.2023.1081543"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1081543","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fendo.2023.1208563","asserted-by":"object"}]},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,27]]},"article-number":"1081543"}}